BrainStorm Cell Therapeutics Submits IND Amendment to FDA, Paving the Way for Phase 3b Trial of NurOwn in ALS  StreetInsider

View original post here:

BrainStorm Cell Therapeutics Submits IND Amendment to FDA, Paving the Way for Phase 3b Trial of NurOwn in ALS - StreetInsider

Related Post

Leave a comment

Your email address will not be published. Required fields are marked *


Refresh